Keywords : Thymoptinum
Disorders Of The Immune System And Their Immunological Rehabilitation In Patients With Chronic Pancreatitis
European Journal of Molecular & Clinical Medicine,
2020, Volume 7, Issue 3, Pages 5178-5187
The immune system studied in 36 patients with chronic pancreatitis (CP) and 32 healthy individuals. In patients with CP showed a deficit of T-lymphocytes and subset tension humoral immunity and cytokine profile: TNF–α, IL–4, IL–6. Using thymoptinum (dose of 0.8-1.0 mg per course) in conjunction with conventional treatment in patients with CP led to an increase in cellular immunity and stabilization of cytokine levels.